Month: October 2024
Oct. 16, 2024 – ReproTech Announces New Scientific Advisory Board
ReproTech’s new Scientific Advisory Board will focus on reinforcing the company’s dedication to upholding the highest safety and compliance standards in the cryostorage industry. The Board will provide expert guidance on best practices, regulatory requirements, and innovative approaches to ensure that ReproTech remains the leader in the cryostorage space. This initiative underscores ReproTech’s commitment to protecting the integrity of stored reproductive tissues and maintaining the trust of its clients.
The board comprises of distinguished experts who bring a wealth of experience and knowledge from the fields of Reproductive Science and Assisted Reproductive Technologies. Each member is deeply committed to ReproTech’s mission, serving voluntarily out of a passion for giving back and supporting advancements in these critical areas. Their dedication and expertise are vital in driving the organization’s initiatives forward.
- Kathleen Hwang, MD, Chairperson – Urologist
- Kyle Orwig, Ph.D – Fertility Preservation Specialist
- Marybeth Gerrity, Ph.D, MBA, HCLD – Reproductive Biologist
- Mark Janzen, Ph.D – Infectious Disease Specialist
- Alison Bartolucci, Ph.D, HCLD – Clinical Reproductive Scientist
- Paul Lin, MD – Reproductive Endocrinologist
“We are thrilled to bring together such an esteemed group of experts who will provide invaluable insights and guidance,” said Brad Senstra, CEO of ReproTech. “Their collective expertise will be instrumental in advising us on our operations and business model, ensuring that ReproTech remains at the forefront of the cryostorage industry. This collaboration highlights our commitment to innovation and excellence in safety and compliance.”